Confusable diagnoses · PANCE / PANRE

Major Depressive Disorder vs Bipolar II Disorder and Cyclothymic Disorder

Written & clinically reviewed by Ryan Busch, PA-C · Updated August 2026 · Report an error

Major Depressive Disorder and Bipolar II Disorder and Cyclothymic Disorder are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.

Major Depressive Disorder vs Bipolar II Disorder and Cyclothymic Disorder at a glance

  • Major Depressive Disorder: Persistent depressed mood or anhedonia >=2 weeks with neurovegetative and cognitive symptoms causing functional impairment.
  • Bipolar II Disorder and Cyclothymic Disorder: Mood disorders with hypomanic (not manic) episodes; bipolar II has full depressive episodes, cyclothymia has chronic subthreshold oscillation.

Try two board-style questions on Major Depressive Disorder vs Bipolar II Disorder and Cyclothymic Disorder

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1PsychiatryMedium
A 45-year-old female with major depressive disorder (MDD) has been on sertraline 100 mg daily for 3 years with good response. She is planning to conceive and asks how to safely stop sertraline. Which of the following approaches is most appropriate?
  • AGradual taper over weeks to months
  • BCross-taper to fluoxetine then stop
  • CAlternate-day dosing then stop
  • DTaper over three days then stop
Reveal answer & full explanation
Correct answer: A — Gradual taper over weeks to months
  • AGradual taper over weeks to months✓
  • BCross-taper to fluoxetine then stop
  • CAlternate-day dosing then stop
  • DTaper over three days then stop

Why Gradual taper over weeks to months is correct

  • Abrupt or rapid discontinuation of sertraline precipitates SSRI discontinuation syndrome
  • SSRI discontinuation syndrome is remembered by the mnemonic FINISH: Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances (electric shock sensations/brain zaps), Hyperarousal and anxiety
  • Recommended tapering rate is approximately 10% per 2-4 weeks
  • Because she is not yet pregnant, the patient and provider have time to complete a proper gradual taper

Why the others are wrong

  • Cross-taper to fluoxetine then stop — fluoxetine's long half-life makes it a rescue strategy when withdrawal occurs, not a routine planned-pregnancy taper (confused-with the rescue indication)
  • Alternate-day dosing then stop — does not constitute a proper gradual taper and can itself precipitate withdrawal (right-concept-wrong-method)
  • Taper over three days then stop — three days after a 3-year course behaves like abrupt cessation and falls far short of the roughly 10% per 2-4 weeks reduction needed to avoid discontinuation syndrome (right-concept-wrong-duration)

Additional high-yield points

  • Paroxetine carries the highest discontinuation risk among SSRIs due to its shortest half-life (~21 hours) plus cholinergic rebound
  • Untreated depression during pregnancy carries risks including premature birth and postpartum depression; sertraline is among the most commonly used SSRIs in pregnancy
Question 2PsychiatryMedium
A 27-year-old woman with bipolar II disorder, diagnosed 3 years ago after recurrent major depressive episodes and discrete 5-day periods of decreased need for sleep and impulsive spending, follows up in clinic. She has had four depressive episodes in the past 2 years, two of which included passive suicidal ideation. She is not currently in a mood episode. Over the course of her illness, which of the following complications is this patient most likely to develop?
  • APersistent depressive disorder
  • BConversion to bipolar I disorder
  • CDeath from a completed suicide
  • DComorbid alcohol use disorder
Reveal answer & full explanation
Correct answer: D — Comorbid alcohol use disorder
  • APersistent depressive disorder
  • BConversion to bipolar I disorder
  • CDeath from a completed suicide
  • DComorbid alcohol use disorder✓

Why Comorbid alcohol use disorder is correct

  • Alcohol use disorder is one of the most common comorbidities of bipolar II. In the Epidemiologic Catchment Area study (Regier et al., JAMA 1990), lifetime alcohol abuse or dependence was about 39% in bipolar II, more than double the 16.5% rate in unipolar major depression.
  • About 2 in 5 patients with bipolar II develop it. The rate is lower in women (29% vs 49% in men in one bipolar outpatient cohort; Frye et al., Am J Psychiatry 2003). Even so, her risk is well above her risk of suicide death or of conversion to bipolar I. That makes it the most likely outcome listed, even though suicide is the one clinicians fear most.
  • Comorbid substance use worsens the course of bipolar disorder: lower remission rates, more hospitalizations, and more suicide attempts (CANMAT/ISBD 2023 update). Screen for alcohol use routinely.

Why the others are wrong

  • Death from a completed suicide — Suicide risk in bipolar disorder is many times that of the general population. A 2024 meta-analysis found the risk in bipolar II is similar to bipolar I, not higher (Dev et al., J Affect Disord 2024). Even so, among people with bipolar disorder, the absolute risk of dying by suicide within up to 36 years of first psychiatric contact is only about 5% in women and 8% in men (Nordentoft et al., Arch Gen Psychiatry 2011). That is far below her likelihood of alcohol use disorder. Female sex is linked to suicide attempts, but only male sex and a first-degree family history of suicide have been significantly linked to suicide deaths (CANMAT/ISBD 2023 update). Her passive ideation calls for safety planning, but it does not make suicide her most likely outcome.
  • Conversion to bipolar I disorder — Only about 5-15% of patients with bipolar II go on to have a full manic episode over long-term follow-up. The diagnosis usually stays stable, so conversion is much less likely than comorbid alcohol use disorder.
  • Persistent depressive disorder — DSM-5-TR rules out persistent depressive disorder once a manic or hypomanic episode has ever occurred, so it cannot be diagnosed in a patient with established bipolar II.

Additional high-yield points

  • Lithium, and to a lesser extent anticonvulsant mood stabilizers, may help prevent suicide attempts and deaths (CANMAT/ISBD 2023 update). Strongly consider lithium for maintenance in any bipolar patient with suicidal ideation or attempts.
  • Bipolar II is often misdiagnosed as unipolar depression for years. Ask about past hypomania before starting an antidepressant, because antidepressants can trigger hypomania, mixed states or rapid cycling.
🔒 Free preview limit reached

Keep comparing — start your free trial

You've used your 2 free previews. Create your free account to see the full Major Depressive Disorder vs Bipolar II Disorder and Cyclothymic Disorder comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.

Start your 7-day free trial → Sign in
Free to start · No credit card · Cancel anytime

Side-by-side comparison

FeatureMajor Depressive DisorderBipolar II Disorder and Cyclothymic Disorder
At a glancePersistent depressed mood or anhedonia >=2 weeks with neurovegetative and cognitive symptoms causing functional impairment.Mood disorders with hypomanic (not manic) episodes; bipolar II has full depressive episodes, cyclothymia has chronic subthreshold oscillation.
Classic presentationSIG E CAPS mnemonic — Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicidality. Five of nine including depressed mood or anhedonia x 2 weeks.; Depressed mood most of the day, nearly every day (self-reported or observed); Markedly diminished interest or pleasure in nearly all activities (anhedonia); Significant…Patient presents with depression and reports past 'best week of my life' periods of needing only 3 hours of sleep, completing massive projects, and spending impulsively — without ever being hospitalized or psychotic.; Hypomania: elevated/expansive or irritable mood, decreased need for sleep, increased energy and goal-directed activity,…
Workup / key labsDSM-5-TR: >=5 of 9 symptoms present for >=2 weeks, with at least one being depressed mood OR anhedonia. Symptoms must cause clinically significant distress/impairment, not be attributable to a substance or medical condition, and not be better explained by a psychotic or bipolar disorder. PHQ-9 >=10 supports diagnosis and tracks severity…Bipolar II: ≥1 hypomanic episode (≥4 days, ≥3 of 7 symptoms, observable change, no marked impairment/psychosis/hospitalization) + ≥1 MDE; never met manic criteria. Cyclothymia: ≥2 yr (≥1 yr youth) of subthreshold hypomanic AND depressive symptoms, ≥half the time, no symptom-free interval >2 mo, criteria for an MDE, manic, or hypomanic…
ImagingNeuroimaging not routine; consider MRI brain if new focal neurologic findings, atypical features, or first episode after age 50Not routinely indicated; Neuroimaging if first episode late-life or focal neurologic findings
First-line treatmentPsychotherapy — cognitive behavioral therapy (CBT) or interpersonal therapy (IPT); comparable to medication for mild-moderate episodes; SSRI — sertraline, escitalopram, fluoxetine (first-line pharmacotherapy; start low, titrate after 2-4 weeks; full effect at 6-8 weeks); SNRI — venlafaxine, duloxetine, desvenlafaxine (consider with…Bipolar II acute depression: quetiapine (best evidence; the only CANMAT first-line agent); lumateperone is also FDA-approved for bipolar II depression (CANMAT second-line), while lurasidone and cariprazine are approved only for bipolar I depression; Bipolar II maintenance: lithium (anti-suicide benefit), lamotrigine (especially if…

Drill Major Depressive Disorder vs Bipolar II Disorder and Cyclothymic Disorder questions on FirstPassPA

Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Full outlines

Major Depressive Disorder (MDD) Bipolar II Disorder and Cyclothymic Disorder All 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.